Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease

Autor: Tomomi Nobashi, Ophir Vermesh, Juliane K. Lohmeyer, Surya Murty, Kenneth Lau, Lukas Scheller, Robert S. Negrin, Aaron T. Mayer, Federico Simonetta, Jeanette Baker, Sanjiv S. Gambhir, Israt S. Alam, Toshihito Hirai
Rok vydání: 2020
Předmět:
0301 basic medicine
Cancer Research
T-Lymphocytes
Cell
Graft vs Host Disease
Disease
Lymphocyte Activation
Article
Mice
03 medical and health sciences
0302 clinical medicine
Downregulation and upregulation
immune system diseases
Positron Emission Tomography Computed Tomography
medicine
Animals
Receptors
OX40/analysis

Tissue Distribution
CD134
Radiopharmaceuticals/pharmacology
Receptor
Copper Radioisotopes/pharmacology
biology
business.industry
Antibodies
Monoclonal

Receptors
OX40

Receptors
OX40/metabolism

Antibodies
Monoclonal/pharmacology

Imaging agent
Transplantation
surgical procedures
operative

030104 developmental biology
medicine.anatomical_structure
Copper Radioisotopes
Oncology
030220 oncology & carcinogenesis
Cancer research
biology.protein
Graft vs Host Disease/immunology
Radiopharmaceuticals
Antibody
business
Positron Emission Tomography Computed Tomography/methods
Zdroj: Cancer Res
Cancer Research, Vol. 80, No 21 (2020) pp. 4780-4790
ISSN: 1538-7445
0008-5472
DOI: 10.1158/0008-5472.can-20-1149
Popis: Graft-versus-host disease (GvHD) is a major complication of allogeneic hematopoietic cell transplantation (HCT), mediated primarily by donor T cells that become activated and attack host tissues. Noninvasive strategies detecting T-cell activation would allow for early diagnosis and possibly more effective management of HCT recipients. PET imaging is a sensitive and clinically relevant modality ideal for GvHD diagnosis, and there is a strong rationale for the use of PET tracers that can monitor T-cell activation and expansion with high specificity. The TNF receptor superfamily member OX40 (CD134) is a cell surface marker that is highly specific for activated T cells, is upregulated during GvHD, and mediates disease pathogenesis. We recently reported the development of an antibody-based activated T-cell imaging agent targeting OX40. In the present study, we visualize the dynamics of OX40 expression in an MHC-mismatch mouse model of acute GvHD using OX40-immunoPET. This approach enabled visualization of T-cell activation at early stages of disease, prior to overt clinical symptoms with high sensitivity and specificity. This study highlights the potential utility of the OX40 PET imaging as a new strategy for GvHD diagnosis and therapy monitoring. Significance: OX40-immunoPET imaging is a promising noninvasive strategy for early detection of GvHD, capable of detecting signs of GvHD pathology even prior to the development of overt clinical symptoms.
Databáze: OpenAIRE